Project Code: 10446052
Faculty: Liggins Institute
Department: Liggins Institute
Main Supervisor: Dist Prof Jane Harding
Principal investigator: Professor Caroline Crowther
Application open date: 22 Feb 2019
Enrolment information: NZ Citizens, NZ Permanent Residents, International
Women who develop diabetes in pregnancy are at risk of later type 2 diabetes and heart disease, and their babies are at risk of obesity and later diabetes.
The aim of the GEMS randomised trial is to find out the best way of diagnosing gestational diabetes to improve pregnancy and birth outcomes, but we also need to know if this has any later benefits for the mother or baby.
Masters or Honours degree or equivalent in a health or education-related discipline and a clinical background. Examples include (but are not limited to) obstetrics, midwifery, paediatrics, medicine, public health.
To determine in the GEMS cohort whether different thresholds for diagnosing gestational diabetes alter:
i) Later health of the women
ii) Outcomes of subsequent pregnancies
ii) Growth, health and development of the children.
- The current research of Distinguished Professor Jane Elizabeth Harding
- What do families want to know about outcomes after trials of new treatments in pregnancy and the newborn?
- Childhood outcomes after a trial of extra protein for babies born very preterm
- Does exposure to antenatal steroids alter cardiovascular risk in middle age?